Holocene Advisors, LP

Position in JNJ — Johnson & Johnson

CIK 1700574 New York, NY

Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,814,255

+$4,529,342 QoQ

Shares Held

18,956

+1003.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,644

of 4,664 holders

Holding Since

Jun 2023

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Jun 30, 2023

CallValue

$243,777,856

CallShares

1,472,800

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names. JNJ ranks #6 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	2,429,349	$460,653,157
2	GILD	Gilead Sciences, Inc.	3,216,892	$406,422,135
3	LLY	ELI LILLY & Co	176,517	$211,719,802
4	NVS	Novartis AG	1,037,332	$162,570,671
5	MRK	Merck & Co., Inc.	628,000	$80,698,000
6	JNJ	Johnson & Johnson This page	18,956	$4,814,255
7	BIIB	Biogen Inc.	4,793	$1,035,575
8	ABBV	AbbVie Inc.	3,855	$970,072

All Filings in JNJ

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,814,255	18,956	+1003.4%	Shares	Sole	2026-08-14
2025-03-31	$284,913	1,718	-94.0%	Shares	Sole	2025-05-15
2024-12-31	$4,128,901	28,550	-97.9%	Shares	Sole	2025-02-14
2024-09-30	$225,039,919	1,388,621	+2200.1%	Shares	Sole	2024-11-14
2023-09-30	$9,402,939	60,372	—	Shares	Sole	2023-11-14
2023-06-30	$243,777,856	1,472,800	—	Call	Sole	2023-08-14
No filing history on record for this holder in this stock.